All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $30,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 2

S 475
Alternatives to PAIN Act
HR 1227
Alternatives to PAIN Act

Lobbying activity 3

Medical/Disease Research/Clinical Labs

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about precision medicine.

Health Issues

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about non-opioid pain therapies.H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Medicare/Medicaid

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about the importance of access to non-opioid pain therapies for Medicare beneficiaries. H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.